Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome–Toxic Epidermal Necrolysis Spectrum Disease-Reference-Cited by-同舟云学术

Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome–Toxic Epidermal Necrolysis Spectrum Disease

Published:2020-08-01 Issue:8 Volume:156 Page:921
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Eliades Philip¹,Fonseca Maíra¹²,Harp Joanna¹

Affiliation:

1. Department of Dermatology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, New York

2. Lincoln Medical Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2765387/jamadermatology_eliades_2020_lo_190024.pdf

Reference6 articles.

1. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.;Zimmermann;JAMA Dermatol,2017

2. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.;Langley;Cochrane Database Syst Rev,2018

3. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.;Sato;Pediatr Int,2018

4. Etanercept therapy for toxic epidermal necrolysis.;Paradisi;J Am Acad Dermatol,2014

5. Randomized, controlled trial of TNF-a antagonist in CTL-mediated severe cutaneous adverse reactions.;Wang;J Clin Invest,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etanercept treatment for pediatric toxic epidermal necrolysis induced by deflazacort: a case report and literature review;Frontiers in Immunology;2024-01-25

2. APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts;Journal of the American Academy of Dermatology;2023-07

3. Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis;Dermatology and Therapy;2023-05-13

4. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis;Annals of Allergy, Asthma & Immunology;2022-09

5. Stevens–Johnson syndrome in children;Current Opinion in Pediatrics;2022-08